---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-089787"
form_type: "8-K"
ticker: "CUE"
cik: "0001645460"
company_name: "Cue Biopharma, Inc."
filed_at: "2022-03-30T23:59:59+00:00"
generated_at: "2026-06-26T13:38:18.193287+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cue Biopharma signs 4-year license for Boston office/lab space; monthly rent $200,700

## Summary
- Lease covers ~13,000 sq ft at 40 Guest Street, Boston; term April 15, 2022 to April 14, 2026.
- Monthly base rent $200,700 first year, escalating 4% annually: Year2 $208,728, Year3 $217,077, Year4 $225,760.
- Initial payment due at signing: $652,220.40 plus parking fees (20 spaces).
- Company plans to relocate corporate headquarters to the Premises in April 2022.
- Licensor (MIL 40G) provides services including gases, chemicals, equipment, IT, security.

## SEC filing metadata
- accession: 0001193125-22-089787
- form_type: 8-K
- ticker: CUE
- cik: 0001645460
- company_name: Cue Biopharma, Inc.
- filed_at: 2022-03-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645460/000119312522089787/0001193125-22-089787-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645460/000119312522089787/d339157d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-089787
- JSON: https://secwatch.observer/filing/0001193125-22-089787.json
- Plain text: https://secwatch.observer/filing/0001193125-22-089787.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.